- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UK-06-0004418
_PRIVATE_LIMITED.webp)
About Morksons Pharmaceuticals (India) Private Limited
Data last updated:
Morksons Pharmaceuticals (India) Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U36912DL2014PTC268669. Its GSTIN is 05AAJCM2820Q1Z6 (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Divesh Kumar and Raj Kumar.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Ga – 33 Flat No. 6 Sf Jawahar Park, New Delhi, Delhi, India – 110062.
As per the financials filed for FY 2020, the company reported a revenue of ₹1.9 Cr, a decline of 51% compared to the previous year. For the same year it recorded a net profit of ₹14,648 (net margin 0.1%) and EBITDA of ₹10.44 Lakh (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 63% over three years.
The company has about 11 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹74.98 Lakh and satisfied charges of ₹25 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
Morksons Pharmaceuticals (India) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0004418). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website morksonspharma.com.
Company details
Recognitions & Rankings of Morksons Pharmaceuticals (India)
Contact details
Morksons Pharmaceuticals (India) Private Limited's registered office is in New Delhi, Delhi. Its website is morksonspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGa – 33 Flat No. 6 Sf Jawahar Park, New Delhi, Delhi, India – 110062
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Morksons Pharmaceuticals (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Morksons Pharmaceuticals (India) is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Morksons Pharmaceuticals (India) Private Limited, buy the company report.
Financials of Morksons Pharmaceuticals (India) Private Limited
FY 2020 filings availableMorksons Pharmaceuticals (India) Private Limited reported revenue of ₹1.9 Cr (down 51% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 51% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 63%. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.9 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.44 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14,648 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Morksons Pharmaceuticals (India) Private Limited, buy the company report.
Board of directors of Morksons Pharmaceuticals (India) Private Limited
Morksons Pharmaceuticals (India) has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Divesh Kumar Also directs: Hormuz Pharma Private Limited | Director | 08 Jul 2014 | 12 Years 3 Months | Current |
| Raj Kumar Also directs: Hormuz Pharma Private Limited | Director | 08 Jul 2014 | 12 Years 3 Months | Current |
Peer comparison
Morksons Pharmaceuticals (India) Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Markwell Pharmaceuticals Private Limited | ₹1.91 Cr (FY 2024) | -1.0% | Agra, Uttar Pradesh, India | |||
| White Maple Pharmaceuticals Private Limited | ₹1.9 Cr (FY 2025) | -12.0% | Dibrugarh, Assam, India | |||
| Morksons Pharmaceuticals (India) Private Limitedthis company | ₹1.9 Cr (FY 2020) | ₹14,648 | 0.1% | -51.0% | New Delhi, Delhi, India | |
| Zenkins Pharmaceuticals Private Limited | ₹1.9 Cr (FY 2025) | 29.0% | Ambala Cantt, Haryana, India | |||
| Morningg Life Pharmaceuticals Private Limited | ₹1.89 Cr (FY 2025) | 28.0% | Varanasi, Uttar Pradesh, India | |||
| Glorritus Pharmaceuticals Private Limited | ₹1.89 Cr (FY 2025) | 7.0% | Kozhikode, Kerala, India |
To see the full peer comparison of Morksons Pharmaceuticals (India) Private Limited, buy the company report.
Auditor
Morksons Pharmaceuticals (India) Private Limited is audited by INDU TANEJA & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| INDU TANEJA & ASSOCIATES | FY 2019 | 018312C |
Shareholding
The shareholding of Morksons Pharmaceuticals (India) Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Morksons Pharmaceuticals (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Jan 2019 | 100255035 | Yes Bank Limited | ₹74.98 Lakh | Open | |
| 01 Aug 2017 | 100133584 | Canara Bank | ₹25 Lakh | Satisfied |
To see the full charge records of Morksons Pharmaceuticals (India) Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Morksons Pharmaceuticals (India) Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Haridwar, Uttarakhand | Interim or miscellaneous application | Filed against the company by M/S India Enterprises | Disposed |
To see the full case history of Morksons Pharmaceuticals (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Morksons Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Morksons Pharmaceuticals (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAJCM2820Q1Z6 | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Morksons Pharmaceuticals (India) Private Limited, buy the company report.
Recent activity
Morksons Pharmaceuticals (India) Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Rajviri Devi ceased to be Director on 10 Mar 2019.
Frequently asked questions
Morksons Pharmaceuticals (India) is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 July 2014 (12+ years old) and is registered under CIN U36912DL2014PTC268669.
Morksons Pharmaceuticals (India) has 2 current directors:
- Divesh Kumar - Director
- Raj Kumar - Director
The latest financial statements of Morksons Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
The GSTIN of Morksons Pharmaceuticals (India) is 05AAJCM2820Q1Z6, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Morksons Pharmaceuticals (India) is U36912DL2014PTC268669. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Morksons Pharmaceuticals (India) has 1 court case on record: 1 filed against it.
Morksons Pharmaceuticals (India) was incorporated on 08 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Morksons Pharmaceuticals (India) by revenue are Markwell Pharmaceuticals Private Limited, White Maple Pharmaceuticals Private Limited, Zenkins Pharmaceuticals Private Limited, Morningg Life Pharmaceuticals Private Limited, Glorritus Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Rajviri Devi ceased to be Director on 10 Mar 2019. Divesh Kumar was appointed as Director on 08 Jul 2014. Raj Kumar was appointed as Director on 08 Jul 2014.
Yes, Morksons Pharmaceuticals (India) is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-06-0004418).
Morksons Pharmaceuticals (India) can be reached through the website morksonspharma.com. Its registered office is in New Delhi, Delhi, India.

